| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.72e-07 | 125 | 40 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.25e-07 | 151 | 40 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.09e-06 | 171 | 40 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PTCH2 IL10RB NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E PTCH1 SSTR2 OR51B2 OR9A2 | 8.40e-06 | 1353 | 40 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 1.17e-05 | 3 | 40 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | smoothened binding | 2.34e-05 | 4 | 40 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 2.34e-05 | 4 | 40 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.60e-05 | 86 | 40 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 4.97e-05 | 884 | 40 | 9 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 5.29e-05 | 103 | 40 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.43e-04 | 133 | 40 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.45e-04 | 51 | 40 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.63e-04 | 53 | 40 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.74e-04 | 140 | 40 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.13e-04 | 11 | 40 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 3.01e-04 | 13 | 40 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.22e-04 | 17 | 40 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 7.27e-04 | 20 | 40 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 7.27e-04 | 20 | 40 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 8.81e-04 | 22 | 40 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 8.81e-04 | 22 | 40 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.43e-03 | 28 | 40 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.49e-03 | 37 | 40 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | transporter activity | 3.55e-03 | 1289 | 40 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.74e-03 | 758 | 40 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.37e-03 | 334 | 40 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.51e-03 | 50 | 40 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.66e-03 | 793 | 40 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.05e-03 | 196 | 40 | 3 | GO:0005319 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 9.65e-03 | 74 | 40 | 2 | GO:0005548 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.44e-06 | 112 | 40 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | chloride transport | 4.70e-06 | 128 | 40 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 5.89e-06 | 134 | 40 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.12e-05 | 153 | 40 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.46e-05 | 180 | 40 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.66e-05 | 183 | 40 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 5.47e-05 | 6 | 40 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 9.62e-05 | 124 | 40 | 4 | GO:0007218 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 1.63e-04 | 10 | 40 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 1.65e-04 | 55 | 40 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 2.14e-04 | 60 | 40 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.72e-04 | 65 | 40 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic nucleotide receptor signaling pathway | 2.82e-04 | 13 | 40 | 2 | GO:0035589 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.77e-04 | 57 | 40 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | trans-Golgi network | 2.81e-04 | 306 | 40 | 5 | GO:0005802 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 3.20e-04 | 14 | 40 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.49e-03 | 443 | 40 | 5 | GO:0098791 | |
| HumanPheno | Odontogenic keratocysts of the jaw | 2.42e-05 | 3 | 15 | 2 | HP:0010603 | |
| HumanPheno | Cardiac fibroma | 2.42e-05 | 3 | 15 | 2 | HP:0010617 | |
| HumanPheno | Ovarian fibroma | 2.42e-05 | 3 | 15 | 2 | HP:0010618 | |
| HumanPheno | Bridged sella turcica | 2.42e-05 | 3 | 15 | 2 | HP:0005449 | |
| HumanPheno | Hypokalemic hypochloremic metabolic alkalosis | 2.42e-05 | 3 | 15 | 2 | HP:0004909 | |
| HumanPheno | Hypochloremic metabolic alkalosis | 4.84e-05 | 4 | 15 | 2 | HP:0005977 | |
| HumanPheno | Plantar pits | 4.84e-05 | 4 | 15 | 2 | HP:0010612 | |
| HumanPheno | Abnormal urine chloride concentration | 8.05e-05 | 5 | 15 | 2 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 8.05e-05 | 5 | 15 | 2 | HP:0002914 | |
| HumanPheno | Hyperprostaglandinuria | 1.21e-04 | 6 | 15 | 2 | HP:0003527 | |
| HumanPheno | Abnormal circulating prostaglandin circulation | 1.21e-04 | 6 | 15 | 2 | HP:0011023 | |
| HumanPheno | Chronic kidney disease | 1.67e-04 | 194 | 15 | 5 | HP:0012622 | |
| HumanPheno | Hypochloremia | 1.69e-04 | 7 | 15 | 2 | HP:0003113 | |
| HumanPheno | Calcification of falx cerebri | 1.69e-04 | 7 | 15 | 2 | HP:0005462 | |
| HumanPheno | Impaired renal concentrating ability | 1.69e-04 | 7 | 15 | 2 | HP:0004727 | |
| HumanPheno | Nasogastric tube feeding | 2.21e-04 | 42 | 15 | 3 | HP:0040288 | |
| HumanPheno | Hyperactive renin-angiotensin system | 2.24e-04 | 8 | 15 | 2 | HP:0000841 | |
| HumanPheno | Odontogenic neoplasm | 2.24e-04 | 8 | 15 | 2 | HP:0100612 | |
| HumanPheno | Abnormal circulating unsaturated fatty acid concentration | 2.24e-04 | 8 | 15 | 2 | HP:0011022 | |
| HumanPheno | Abnormal circulating eicosanoid concentration | 2.24e-04 | 8 | 15 | 2 | HP:0030361 | |
| HumanPheno | Acute kidney injury | 2.55e-04 | 44 | 15 | 3 | HP:0001919 | |
| HumanPheno | Tube feeding | 2.71e-04 | 215 | 15 | 5 | HP:0033454 | |
| HumanPheno | Impaired renal function | 2.88e-04 | 9 | 15 | 2 | HP:0000087 | |
| HumanPheno | Hypokalemic metabolic alkalosis | 2.88e-04 | 9 | 15 | 2 | HP:0001960 | |
| HumanPheno | Minor hand anomalies | 2.88e-04 | 9 | 15 | 2 | HP:0003098 | |
| HumanPheno | Increased urinary potassium | 2.88e-04 | 9 | 15 | 2 | HP:0003081 | |
| HumanPheno | Palmar pits | 2.88e-04 | 9 | 15 | 2 | HP:0010610 | |
| HumanPheno | Hypernatriuria | 3.59e-04 | 10 | 15 | 2 | HP:0012605 | |
| HumanPheno | Stage 5 chronic kidney disease | 5.13e-04 | 135 | 15 | 4 | HP:0003774 | |
| HumanPheno | Hypokalemic alkalosis | 5.25e-04 | 12 | 15 | 2 | HP:0001949 | |
| HumanPheno | Fetal polyuria | 5.25e-04 | 12 | 15 | 2 | HP:0001563 | |
| HumanPheno | Hyponatremia | 6.39e-04 | 60 | 15 | 3 | HP:0002902 | |
| HumanPheno | Neoplasm of the heart | 8.31e-04 | 15 | 15 | 2 | HP:0100544 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 8.45e-04 | 154 | 15 | 4 | HP:0010930 | |
| HumanPheno | Digenic inheritance | 9.48e-04 | 16 | 15 | 2 | HP:0010984 | |
| HumanPheno | Abnormal urine output | 9.63e-04 | 69 | 15 | 3 | HP:0012590 | |
| HumanPheno | Delayed ability to stand | 1.07e-03 | 17 | 15 | 2 | HP:0025335 | |
| HumanPheno | Bifid ribs | 1.07e-03 | 17 | 15 | 2 | HP:0000892 | |
| HumanPheno | Severe failure to thrive | 1.07e-03 | 17 | 15 | 2 | HP:0001525 | |
| HumanPheno | Abnormal blood sodium concentration | 1.09e-03 | 72 | 15 | 3 | HP:0010931 | |
| HumanPheno | Metabolic alkalosis | 1.21e-03 | 18 | 15 | 2 | HP:0200114 | |
| HumanPheno | Abnormal urine sodium concentration | 1.21e-03 | 18 | 15 | 2 | HP:0012603 | |
| HumanPheno | Abnormal urine potassium concentration | 1.21e-03 | 18 | 15 | 2 | HP:0012598 | |
| HumanPheno | Abnormality of renal excretion | 1.23e-03 | 75 | 15 | 3 | HP:0011036 | |
| HumanPheno | Vertebral wedging | 1.34e-03 | 19 | 15 | 2 | HP:0008422 | |
| HumanPheno | Anterior rib cupping | 1.34e-03 | 19 | 15 | 2 | HP:0000907 | |
| HumanPheno | Increased circulating renin concentration | 1.34e-03 | 19 | 15 | 2 | HP:0000848 | |
| HumanPheno | Medulloblastoma | 1.34e-03 | 19 | 15 | 2 | HP:0002885 | |
| HumanPheno | Deformed sella turcica | 1.49e-03 | 20 | 15 | 2 | HP:0002681 | |
| HumanPheno | Generalized osteosclerosis | 1.59e-03 | 82 | 15 | 3 | HP:0005711 | |
| HumanPheno | Osteosclerosis | 1.59e-03 | 82 | 15 | 3 | HP:0010738 | |
| Domain | Cl_channel-K | 4.47e-06 | 2 | 40 | 2 | IPR002250 | |
| Domain | TM_rcpt_patched | 4.47e-06 | 2 | 40 | 2 | IPR004766 | |
| Domain | GPCR_Rhodpsn_7TM | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 9.40e-06 | 670 | 40 | 9 | IPR017452 |
| Domain | 7tm_1 | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 1.02e-05 | 677 | 40 | 9 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 1.12e-05 | 685 | 40 | 9 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 1.20e-05 | 691 | 40 | 9 | PS50262 |
| Domain | GPCR_Rhodpsn | NPFFR2 P2RY14 CYSLTR2 GPR171 OR10AG1 HTR1E SSTR2 OR51B2 OR9A2 | 1.22e-05 | 692 | 40 | 9 | IPR000276 |
| Domain | Cl-channel_core | 1.59e-04 | 9 | 40 | 2 | IPR014743 | |
| Domain | Ptc/Disp | 1.59e-04 | 9 | 40 | 2 | IPR003392 | |
| Domain | Patched | 1.59e-04 | 9 | 40 | 2 | PF02460 | |
| Domain | - | 1.59e-04 | 9 | 40 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.59e-04 | 9 | 40 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.59e-04 | 9 | 40 | 2 | IPR001807 | |
| Domain | Hydrolase_3 | 1.99e-04 | 10 | 40 | 2 | PF08282 | |
| Domain | SSD | 3.44e-04 | 13 | 40 | 2 | PS50156 | |
| Domain | SSD | 3.44e-04 | 13 | 40 | 2 | IPR000731 | |
| Domain | P_typ_ATPase_c | 4.00e-04 | 14 | 40 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 4.00e-04 | 14 | 40 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 4.00e-04 | 14 | 40 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 4.00e-04 | 14 | 40 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 4.00e-04 | 14 | 40 | 2 | PF16209 | |
| Domain | CBS | 5.27e-04 | 16 | 40 | 2 | SM00116 | |
| Domain | CBS_dom | 8.29e-04 | 20 | 40 | 2 | IPR000644 | |
| Domain | CBS | 8.29e-04 | 20 | 40 | 2 | PF00571 | |
| Domain | CBS | 8.29e-04 | 20 | 40 | 2 | PS51371 | |
| Domain | 7TM_GPCR_Srsx | 1.76e-03 | 112 | 40 | 3 | SM01381 | |
| Domain | - | 2.13e-03 | 32 | 40 | 2 | 2.70.150.10 | |
| Domain | - | 2.13e-03 | 32 | 40 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 2.54e-03 | 35 | 40 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.69e-03 | 36 | 40 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 2.69e-03 | 36 | 40 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.69e-03 | 36 | 40 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.84e-03 | 37 | 40 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.84e-03 | 37 | 40 | 2 | PF00122 | |
| Domain | - | 8.29e-03 | 64 | 40 | 2 | 3.40.50.1000 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.98e-06 | 176 | 31 | 6 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.48e-06 | 183 | 31 | 6 | M997 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.86e-05 | 260 | 31 | 6 | M39397 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 5.22e-05 | 463 | 31 | 7 | M507 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.23e-05 | 99 | 31 | 4 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.13e-05 | 106 | 31 | 4 | M27200 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 8.34e-05 | 681 | 31 | 8 | MM14985 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 9.76e-05 | 7 | 31 | 2 | M27501 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.43e-04 | 736 | 31 | 8 | M27287 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 1.67e-04 | 9 | 31 | 2 | M47893 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.90e-04 | 272 | 31 | 5 | M13380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 4.19e-04 | 14 | 31 | 2 | M47414 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 5.51e-04 | 16 | 31 | 2 | M39675 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 6.79e-04 | 702 | 31 | 7 | M746 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 7.02e-04 | 330 | 31 | 5 | M18334 | |
| Pathway | PID_HEDGEHOG_2PATHWAY | 1.05e-03 | 22 | 31 | 2 | M211 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 1.05e-03 | 22 | 31 | 2 | MM15924 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.83e-03 | 29 | 31 | 2 | M47377 | |
| Pathway | WP_GPCRS_NONODORANT | 2.61e-03 | 266 | 31 | 4 | MM15843 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 4.00e-03 | 43 | 31 | 2 | M39706 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 1.29e-06 | 2 | 40 | 2 | 8544406 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34990798 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 1.29e-06 | 2 | 40 | 2 | 27335120 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8812470 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 1.29e-06 | 2 | 40 | 2 | 20805576 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 25919862 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 1.29e-06 | 2 | 40 | 2 | 9916798 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9916791 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19221557 | ||
| Pubmed | Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression. | 1.29e-06 | 2 | 40 | 2 | 26834157 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30166346 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 1.29e-06 | 2 | 40 | 2 | 15044642 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 29230040 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 1.29e-06 | 2 | 40 | 2 | 38069401 | |
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 1.29e-06 | 2 | 40 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 1.29e-06 | 2 | 40 | 2 | 18648499 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 11014860 | ||
| Pubmed | Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional. | 3.87e-06 | 3 | 40 | 2 | 26013830 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 25085974 | ||
| Pubmed | Barttin increases surface expression and changes current properties of ClC-K channels. | 3.87e-06 | 3 | 40 | 2 | 12111250 | |
| Pubmed | Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. | 3.87e-06 | 3 | 40 | 2 | 11734858 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 17510212 | ||
| Pubmed | Barttin modulates trafficking and function of ClC-K channels. | 3.87e-06 | 3 | 40 | 2 | 16849430 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 31145830 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 18094726 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10982849 | ||
| Pubmed | Mechanism of inhibition of the tumor suppressor Patched by Sonic Hedgehog. | 3.87e-06 | 3 | 40 | 2 | 27647915 | |
| Pubmed | Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehog. | 3.87e-06 | 3 | 40 | 2 | 9462734 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 17652939 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 33047712 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 12880872 | ||
| Pubmed | Fibroblast growth factor 10 is required for proper development of the mouse whiskers. | 7.73e-06 | 4 | 40 | 2 | 12615071 | |
| Pubmed | Functions of sorting nexin 17 domains and recognition motif for P-selectin trafficking. | 7.73e-06 | 4 | 40 | 2 | 15769472 | |
| Pubmed | Overlapping and non-overlapping Ptch2 expression with Shh during mouse embryogenesis. | 7.73e-06 | 4 | 40 | 2 | 9858693 | |
| Pubmed | Patched1 and Patched2 inhibit Smoothened non-cell autonomously. | 1.29e-05 | 5 | 40 | 2 | 27552050 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 11758785 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 34353359 | ||
| Pubmed | Hedgehog and patched gene expression in adult ocular tissues. | 1.29e-05 | 5 | 40 | 2 | 9237688 | |
| Pubmed | Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. | 1.93e-05 | 6 | 40 | 2 | 19487286 | |
| Pubmed | Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. | 1.93e-05 | 6 | 40 | 2 | 11524702 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 38442711 | ||
| Pubmed | Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency. | 2.70e-05 | 7 | 40 | 2 | 34499620 | |
| Pubmed | Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. | 2.70e-05 | 7 | 40 | 2 | 11423561 | |
| Pubmed | Characterization of two patched receptors for the vertebrate hedgehog protein family. | 2.70e-05 | 7 | 40 | 2 | 9811851 | |
| Pubmed | CDC50 proteins are critical components of the human class-1 P4-ATPase transport machinery. | 2.70e-05 | 7 | 40 | 2 | 20961850 | |
| Pubmed | Patched Receptors Sense, Interpret, and Establish an Epidermal Hedgehog Signaling Gradient. | 3.60e-05 | 8 | 40 | 2 | 27498049 | |
| Pubmed | Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. | 3.60e-05 | 8 | 40 | 2 | 10027293 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 22869526 | ||
| Pubmed | Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. | 3.60e-05 | 8 | 40 | 2 | 10529434 | |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 4.62e-05 | 9 | 40 | 2 | 23115349 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 18591670 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 18832395 | ||
| Pubmed | The sonic hedgehog-patched-gli pathway in human development and disease. | 4.62e-05 | 9 | 40 | 2 | 11001584 | |
| Pubmed | Patched2 modulates tumorigenesis in patched1 heterozygous mice. | 4.62e-05 | 9 | 40 | 2 | 16849540 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 11784021 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 10512189 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 24318810 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 11311154 | ||
| Pubmed | Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling. | 5.77e-05 | 10 | 40 | 2 | 28344083 | |
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 15668330 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 9671585 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 10465785 | ||
| Pubmed | Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. | 7.05e-05 | 11 | 40 | 2 | 17442700 | |
| Pubmed | Genetically engineered mouse models of brain cancer and the promise of preclinical testing. | 8.45e-05 | 12 | 40 | 2 | 19076778 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 19445942 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 11389830 | ||
| Pubmed | Attenuated sensing of SHH by Ptch1 underlies evolution of bovine limbs. | 8.45e-05 | 12 | 40 | 2 | 24990743 | |
| Pubmed | Hedgehog signaling regulates differentiation from double-negative to double-positive thymocyte. | 8.45e-05 | 12 | 40 | 2 | 10981962 | |
| Pubmed | Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina. | 8.45e-05 | 12 | 40 | 2 | 18417110 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 36459481 | ||
| Pubmed | A role for Saccharomyces cerevisiae Centrin (Cdc31) in mitochondrial function and biogenesis. | 8.45e-05 | 12 | 40 | 2 | 30251372 | |
| Pubmed | Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development. | 9.98e-05 | 13 | 40 | 2 | 25448692 | |
| Pubmed | Expression patterns of Hedgehog signalling pathway members during mouse palate development. | 9.98e-05 | 13 | 40 | 2 | 16168717 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 32332736 | ||
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 9.98e-05 | 13 | 40 | 2 | 11015572 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 18625210 | ||
| Pubmed | Gli2 influences proliferation in the developing lung through regulation of cyclin expression. | 9.98e-05 | 13 | 40 | 2 | 19574535 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 15563592 | ||
| Pubmed | Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia. | 1.16e-04 | 14 | 40 | 2 | 16914743 | |
| Pubmed | Sonic hedgehog regulates branching morphogenesis in the mammalian lung. | 1.16e-04 | 14 | 40 | 2 | 9768363 | |
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 25458012 | ||
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 9768360 | ||
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 23900540 | ||
| Pubmed | GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling. | 1.53e-04 | 16 | 40 | 2 | 26932670 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 17631878 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 23034632 | ||
| Pubmed | Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. | 1.53e-04 | 16 | 40 | 2 | 12533516 | |
| Pubmed | Ciliary and extraciliary Gpr161 pools repress hedgehog signaling in a tissue-specific manner. | 1.53e-04 | 16 | 40 | 2 | 34346313 | |
| Pubmed | Activated Hedgehog-GLI Signaling Causes Congenital Ureteropelvic Junction Obstruction. | 1.53e-04 | 16 | 40 | 2 | 29109083 | |
| Pubmed | Aberrant and constitutive expression of FOXL2 impairs ovarian development and functions in mice. | 1.73e-04 | 17 | 40 | 2 | 32945847 | |
| Pubmed | Manifestation of the limb prepattern: limb development in the absence of sonic hedgehog function. | 1.95e-04 | 18 | 40 | 2 | 11476582 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 34893605 | ||
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 19570847 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 28202523 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 37516749 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 18206867 | ||
| Pubmed | Patched 1 and patched 2 redundancy has a key role in regulating epidermal differentiation. | 2.18e-04 | 19 | 40 | 2 | 24492243 | |
| Pubmed | Essential roles of G9a in cell proliferation and differentiation during tooth development. | 2.42e-04 | 20 | 40 | 2 | 28527696 | |
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 20637749 | ||
| Cytoband | 1p36 | 7.81e-04 | 47 | 40 | 2 | 1p36 | |
| GeneFamily | Chloride voltage-gated channels | 1.03e-04 | 10 | 28 | 2 | 302 | |
| GeneFamily | ATPase phospholipid transporting | 2.40e-04 | 15 | 28 | 2 | 1210 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 7.04e-05 | 399 | 38 | 6 | GSM538345_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 7.64e-05 | 405 | 38 | 6 | GSM538343_500 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 166 | 40 | 4 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 40 | 4 | 1558606be0a8bcd4fd0ce609701a1411e4ca2f9f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 169 | 40 | 4 | 1b2354de1ce4080118d9f01e7c5fd6079e705125 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 176 | 40 | 4 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-05 | 190 | 40 | 4 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-05 | 194 | 40 | 4 | d024cd75a97f048257e49cee9190fb2e79202ee2 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.82e-05 | 196 | 40 | 4 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-04 | 134 | 40 | 3 | 92981dc68c1b3cdc53f9cf83386c47f0c6c98ae7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-04 | 143 | 40 | 3 | 92ddc3e3f6ba78dd9daeb272c12503ec2650a874 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-04 | 145 | 40 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-04 | 146 | 40 | 3 | 669001b772b6d6109a09727619ed5829122b48db | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 148 | 40 | 3 | 3aa47398cb805c6c6e16b375cc3e9c7f04bb91f4 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 150 | 40 | 3 | c18d3f66b384ec9ee0b8fb6a369b9a524b5dcaeb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-04 | 153 | 40 | 3 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.61e-04 | 155 | 40 | 3 | d8e9f355ce933f6383c3d1e35ff55235a95c7fcd | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 155 | 40 | 3 | cc3fc379ea78742a216317054f336331f7c7a157 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 155 | 40 | 3 | 1900a76754e2a9c7117e531c5907b7942f72c4a6 | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 3.68e-04 | 156 | 40 | 3 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-5|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.75e-04 | 157 | 40 | 3 | 59450e9f580555091b159fbbe0a0756e51bcd9ad | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 158 | 40 | 3 | 5d926be5a0ebe8257cd552afa7844171f9ff01c0 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 3.96e-04 | 160 | 40 | 3 | 1b73a14ad6546d9f2812c19081278a79260abeae | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-04 | 160 | 40 | 3 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-04 | 160 | 40 | 3 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-04 | 160 | 40 | 3 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-04 | 160 | 40 | 3 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.11e-04 | 162 | 40 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.11e-04 | 162 | 40 | 3 | 2d28306c6125b31f11ea6d911a167b93a74907c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.18e-04 | 163 | 40 | 3 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-04 | 164 | 40 | 3 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.33e-04 | 165 | 40 | 3 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.33e-04 | 165 | 40 | 3 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 166 | 40 | 3 | d1c61270c7b39bb365020eeafe298a8f88aa887e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 4.41e-04 | 166 | 40 | 3 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.41e-04 | 166 | 40 | 3 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 168 | 40 | 3 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 168 | 40 | 3 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 168 | 40 | 3 | 3db0453296914011b733b82234b3e8e45ebc86b6 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.64e-04 | 169 | 40 | 3 | 45ac692a0c9064ce6b6a31c2cd21c85ccf594670 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-04 | 169 | 40 | 3 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 630d921aa8fb5681d06a4e09b833855c374be484 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 468284d4a3a0557aed04eadb1aba2317babc6904 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-04 | 169 | 40 | 3 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 169 | 40 | 3 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 169 | 40 | 3 | 6f765e142d127545e622fe24b5287cd6e9706ccc | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.64e-04 | 169 | 40 | 3 | 3514a74980c7bd4bb76dbd06693f492e8dce21e0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.72e-04 | 170 | 40 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-04 | 170 | 40 | 3 | a7184dc41f90caa753860ed0f65a18133f84bc5f | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.89e-04 | 172 | 40 | 3 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 4.89e-04 | 172 | 40 | 3 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.89e-04 | 172 | 40 | 3 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | 25d72fa7a84baf5660ead6da67327590f5c91860 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | 886ac1b98f709ad7131df778b83712bf8ed313de | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-04 | 173 | 40 | 3 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-04 | 173 | 40 | 3 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-04 | 173 | 40 | 3 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 174 | 40 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 174 | 40 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.06e-04 | 174 | 40 | 3 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 176 | 40 | 3 | 7b3f3d9b33770edf294cee0eccaf8a46f9331461 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 176 | 40 | 3 | 9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 176 | 40 | 3 | 3d372c1d527fcc118d1e5809f2524fc387682472 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 5.23e-04 | 176 | 40 | 3 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.40e-04 | 178 | 40 | 3 | a34bb693b72684cbd97ac9efff77d2d14e41be75 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | ba5a477257877f4a15a91c1762ffcc6f2e9f7357 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-04 | 178 | 40 | 3 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | 5634c1fbc817758092af4feafff94d107412d89b | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.49e-04 | 179 | 40 | 3 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.49e-04 | 179 | 40 | 3 | 9fc44637c9a7551fd47b8533e45a9c199e164a95 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | e5bbd0e204da4f98254e3484b383ec1c277b4209 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | 46de8c18e4ec8dc9d07f7c8cc7b5f48b9c613aae | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.67e-04 | 181 | 40 | 3 | 477c572c5c1efceee49732cc9e8b1dad68a7e6e5 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 5.67e-04 | 181 | 40 | 3 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-04 | 181 | 40 | 3 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-B_cell-B_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.67e-04 | 181 | 40 | 3 | 909280b44085d8e96fcd3cbcba6bff94badd41e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-04 | 181 | 40 | 3 | ce0e39114bf3bcbcce0fd4c0d70bedadd0853e1d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-04 | 182 | 40 | 3 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-04 | 182 | 40 | 3 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.76e-04 | 182 | 40 | 3 | 9d727ab84da8de33f1021b492c90d8b4c2a8ea23 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-04 | 182 | 40 | 3 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.76e-04 | 182 | 40 | 3 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | remission-B_naive|World / disease stage, cell group and cell class | 5.76e-04 | 182 | 40 | 3 | cc1dfd2de35aee1a26f7efd78e108b60a3556ec5 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-B_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | fd72663bf990266da2fba70d4f2260f8d48067ee | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.95e-04 | 184 | 40 | 3 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | a740ceffa62175578e6cff62da1f8dfaf40098e5 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.95e-04 | 184 | 40 | 3 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-04 | 184 | 40 | 3 | ca35a3d2b536c8b2bf5c4d635605e5a3ae94a428 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_EGR3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-04 | 184 | 40 | 3 | 219bd3b8daa0a713fb6a8a5e1bb35cdb85bb7727 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | f6148e9591e8845cc62668e49fd52755257cdc7e | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 185 | 40 | 3 | d4076294571557c223f5b68244e9c53e1d8f0343 | |
| ToppCell | IIF-Lymphocyte-B-B_naive|IIF / Disease, Lineage and Cell Type | 6.04e-04 | 185 | 40 | 3 | dec48908addfc71f32f5ce0ce73f2926e476f60b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-04 | 185 | 40 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.04e-04 | 185 | 40 | 3 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | BLOOD--(2)_Naive_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.14e-04 | 186 | 40 | 3 | 2e55a3892459152fc4a3a7834ccbf5d71b65d29a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 186 | 40 | 3 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 1.61e-06 | 2 | 38 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | Bartter disease type 4b (is_implicated_in) | 1.61e-06 | 2 | 38 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease type 4B | 1.61e-06 | 2 | 38 | 2 | cv:C4310805 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.61e-06 | 2 | 38 | 2 | 613090 | |
| Disease | Bartter disease (implicated_via_orthology) | 1.61e-06 | 2 | 38 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B | 1.61e-06 | 2 | 38 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.61e-06 | 2 | 38 | 2 | C4310805 | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 9.67e-06 | 4 | 38 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 9.67e-06 | 4 | 38 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 9.67e-06 | 4 | 38 | 2 | C0812437 | |
| Disease | Basal Cell Nevus Syndrome | 1.61e-05 | 5 | 38 | 2 | C0004779 | |
| Disease | Choledochal Cyst, Type I | 1.61e-05 | 5 | 38 | 2 | C0009439 | |
| Disease | Choledochal Cyst | 1.61e-05 | 5 | 38 | 2 | C0008340 | |
| Disease | Choledochal Cyst, Type II | 1.61e-05 | 5 | 38 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 1.61e-05 | 5 | 38 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 1.61e-05 | 5 | 38 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 1.61e-05 | 5 | 38 | 2 | C1257799 | |
| Disease | Bartter syndrome | 2.41e-05 | 6 | 38 | 2 | cv:C0004775 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.63e-05 | 145 | 38 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 5.78e-05 | 9 | 38 | 2 | C0085548 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 7.22e-05 | 10 | 38 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 8.82e-05 | 11 | 38 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.06e-04 | 12 | 38 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | stroke outcome severity measurement | 4.29e-04 | 114 | 38 | 3 | EFO_0009603 | |
| Disease | Pigmented Basal Cell Carcinoma | 5.98e-04 | 28 | 38 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 6.41e-04 | 29 | 38 | 2 | C4721806 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 8.31e-04 | 33 | 38 | 2 | DOID:10003 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | 9.71e-04 | 904 | 38 | 6 | EFO_0004736 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.09e-03 | 157 | 38 | 3 | DOID:14330 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLVIVMTVMSLLVLV | 241 | Q9H313 | |
| MTVMSLLVLVLSWGS | 246 | Q9H313 | |
| VWMMVASLLPAILVF | 991 | P04920 | |
| VTLWMSLVVTSMVAV | 466 | Q75V66 | |
| GVLDIPMISWVVMLV | 2161 | Q9NR09 | |
| PMISWVVMLVSRLLD | 2166 | Q9NR09 | |
| LMILTVWTISIFISM | 141 | P28566 | |
| WSFLILLSVTIPMSM | 431 | O60423 | |
| TWFTTIVPLVLVITM | 76 | Q8TF62 | |
| MDLSLLWVLLPLVTM | 1 | Q07507 | |
| IMIIWVLAITIMSPS | 266 | Q9Y5X5 | |
| LIPPMDLLEMIVTWI | 196 | Q96N11 | |
| TIIIPRMLMDIWTQK | 66 | Q8NH19 | |
| MHTVTIWLTVRPDMT | 66 | Q9BYM8 | |
| VTLTTMPTVMGILWV | 71 | Q9Y5P1 | |
| TVVWLMVLLIMVPNM | 136 | O14626 | |
| TTVWPTMITPMLLTL | 6 | P03928 | |
| VLLLTMMSTAPQPVW | 516 | Q9UJY4 | |
| DWMVMRLLTSNIIVT | 996 | Q8IZD9 | |
| PNLIWIIIMMVLTQL | 41 | O15121 | |
| ETVPSWMVAVILMAS | 216 | Q08334 | |
| AVILTASPWMVSMTV | 256 | Q8WVV5 | |
| ASPWMVSMTVILAVF | 261 | Q8WVV5 | |
| MKVTGITILFWPLSM | 1 | Q9H756 | |
| LVTTIIVPMMLWGLL | 71 | Q8NGT5 | |
| LMLTTWLLPLTIMAS | 66 | P03905 | |
| MALAMLVLVVSPWSA | 1 | Q9BYC8 | |
| ITMALSWMTIVVPLL | 211 | Q8NFB2 | |
| PWTAGLIVLVLAMMT | 986 | Q9Y6C5 | |
| WTAGIIVMVLALMTV | 1051 | Q13635 | |
| ISVTMILVAWMVIAL | 51 | Q96QK8 | |
| MTAWLISLMSIEVLL | 1 | P08F94 | |
| LIIVPTSVMLNWEME | 671 | Q6ZRS2 | |
| LSVIVWMLMLLLAVP | 141 | Q15391 | |
| WMLMLLLAVPNIILT | 146 | Q15391 | |
| MITMAVWGVSLLVIL | 161 | P30874 | |
| PTAVMVVLIMVWDGI | 1511 | Q8NFU7 | |
| LVMKFWMLILATTIP | 406 | P51800 | |
| LVMKFWMLILATTIP | 406 | P51801 | |
| IIWILIMASSIMLLD | 161 | Q9NS75 | |
| SSMELQVWTLLLIMI | 2126 | O75443 | |
| WVTITSPQAIMMSIC | 361 | Q15036 | |
| SIISMMKQRTEPWTV | 56 | Q5HY98 | |
| PLLWQSAIMILTMLL | 76 | Q8N2U9 | |
| WRPVLMMCVVLTTLP | 86 | Q5W0B7 | |
| VAILEPTLPIWMMQT | 316 | P54219 |